360 NEWS360 NEWS

Business · National

Danes Are Crooning Over Novo Despite Drugmaker’s Share Slump

It’s been a painful couple of years for Denmark’s nearly 700,000-strong army of retail investors in Novo Nordisk A/S as the weight-loss drugmaker has lost market share to US rival Eli Lilly & Co.

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Danes Are Crooning Over Novo Despite Drugmaker’s Share Slump”?

This is self-selected reader participation, not representative scientific polling.